1. Home
  2. PBM vs POAI Comparison

PBM vs POAI Comparison

Compare PBM & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBM
  • POAI
  • Stock Information
  • Founded
  • PBM 1994
  • POAI 2002
  • Country
  • PBM Canada
  • POAI United States
  • Employees
  • PBM N/A
  • POAI N/A
  • Industry
  • PBM
  • POAI Industrial Specialties
  • Sector
  • PBM
  • POAI Health Care
  • Exchange
  • PBM NYSE
  • POAI Nasdaq
  • Market Cap
  • PBM 5.3M
  • POAI 9.7M
  • IPO Year
  • PBM N/A
  • POAI N/A
  • Fundamental
  • Price
  • PBM $1.40
  • POAI $1.62
  • Analyst Decision
  • PBM
  • POAI Hold
  • Analyst Count
  • PBM 0
  • POAI 1
  • Target Price
  • PBM N/A
  • POAI N/A
  • AVG Volume (30 Days)
  • PBM 417.9K
  • POAI 2.7M
  • Earning Date
  • PBM 02-02-2025
  • POAI 03-27-2025
  • Dividend Yield
  • PBM N/A
  • POAI N/A
  • EPS Growth
  • PBM N/A
  • POAI N/A
  • EPS
  • PBM N/A
  • POAI N/A
  • Revenue
  • PBM N/A
  • POAI $1,484,223.00
  • Revenue This Year
  • PBM N/A
  • POAI N/A
  • Revenue Next Year
  • PBM N/A
  • POAI $569.48
  • P/E Ratio
  • PBM N/A
  • POAI N/A
  • Revenue Growth
  • PBM N/A
  • POAI N/A
  • 52 Week Low
  • PBM $1.15
  • POAI $0.55
  • 52 Week High
  • PBM $323.25
  • POAI $3.76
  • Technical
  • Relative Strength Index (RSI)
  • PBM 41.45
  • POAI 62.46
  • Support Level
  • PBM $1.15
  • POAI $1.37
  • Resistance Level
  • PBM $1.59
  • POAI $1.58
  • Average True Range (ATR)
  • PBM 0.20
  • POAI 0.13
  • MACD
  • PBM 0.03
  • POAI -0.01
  • Stochastic Oscillator
  • PBM 27.53
  • POAI 93.55

About PBM PSYENCE BIOMEDICAL LTD

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

Share on Social Networks: